{"disease":{"id":"glabellar-rhytides","name":"glabellar rhytides"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02261493","title":"A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":787,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT02261467","title":"A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial Rhytides","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":421,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT01814670","title":"Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":185,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT05517538","title":"Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Mohamed Hayder Oleish Salih","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}